These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 28728274)
41. Bronchiolitis obliterans syndrome following SARS-CoV-2 infection in an allogeneic hematopoietic stem cell recipient. Bondeelle L; Giannotti F; Chalandon Y; Le Goff J; Tapparel C; Bergeron A Am J Transplant; 2023 Jun; 23(6):844-847. PubMed ID: 36972802 [TBL] [Abstract][Full Text] [Related]
42. Bronchiolitis obliterans syndrome in adults after allogeneic stem cell transplantation-pathophysiology, diagnostics and treatment. Grønningsæter IS; Tsykunova G; Lilleeng K; Ahmed AB; Bruserud Ø; Reikvam H Expert Rev Clin Immunol; 2017 Jun; 13(6):553-569. PubMed ID: 28052713 [TBL] [Abstract][Full Text] [Related]
43. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience. Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967 [TBL] [Abstract][Full Text] [Related]
44. CT findings of late-onset noninfectious pulmonary complications in patients with pathologically proven graft-versus-host disease after allogeneic stem cell transplant. Song I; Yi CA; Han J; Kim DH; Lee KS; Kim TS; Chung MJ AJR Am J Roentgenol; 2012 Sep; 199(3):581-7. PubMed ID: 22915397 [TBL] [Abstract][Full Text] [Related]
46. Clinical risk factors and prognostic model for patients with bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. Huang QS; Han TX; Chen Q; Wu J; Zhao P; Wu YJ; He Y; Zhu XL; Fu HX; Wang FR; Zhang YY; Mo XD; Han W; Yan CH; Wang JZ; Chen H; Chen YH; Han TT; Lv M; Chen Y; Wang Y; Xu LP; Liu KY; Huang XJ; Zhang XH Bone Marrow Transplant; 2024 Feb; 59(2):239-246. PubMed ID: 38012449 [TBL] [Abstract][Full Text] [Related]
51. The efficacy of mesenchymal stem cells in bronchiolitis obliterans syndrome after allogeneic HSCT: A multicenter prospective cohort study. Chen S; Zhao K; Lin R; Wang S; Fan Z; Huang F; Chen X; Nie D; Du X; Guo Z; Lin D; Xuan L; Xu N; Sun J; Peng Xiang A; Liu Q EBioMedicine; 2019 Nov; 49():213-222. PubMed ID: 31668569 [TBL] [Abstract][Full Text] [Related]
52. Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation. Zhao Y; OuYang G; Shi J; Luo Y; Tan Y; Yu J; Fu H; Lai X; Liu L; Huang H Front Pharmacol; 2021; 12():668825. PubMed ID: 34262450 [TBL] [Abstract][Full Text] [Related]
53. Clinical observation on the safety and efficacy of umbilical cord mesenchymal stem cells in the treatment of bronchiolitis obliterans after allogeneic haematopoietic stem cell transplantation. Li Z; Wang Y; Li G; Ma N; Li M; Yuan F; Fu Y; Wang L Biotechnol Genet Eng Rev; 2023 Mar; ():1-18. PubMed ID: 36856529 [TBL] [Abstract][Full Text] [Related]
54. Updated prevalence, predictors and treatment outcomes for bronchiolitis obliterans syndrome after allogeneic stem cell transplantation. Pham J; Rangaswamy J; Avery S; Borg B; Martin C; Munsif M; Lin T; Dabscheck E Respir Med; 2021 Feb; 177():106286. PubMed ID: 33383436 [TBL] [Abstract][Full Text] [Related]
55. [Mesenchymal Stem Cells Combined with Budesonide, Almeterol and Azithromycin for the Treatment of Bronchiolitis Obliterans Syndrome after Hematopoietic Stem Cell Transplantation]. Cao XP; Han DM; Wang ZD; Zheng XL; Ding L; Yan HM; Xue M; Zhu L; Liu J; Guo ZK; Wang HX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):173-7. PubMed ID: 26913416 [TBL] [Abstract][Full Text] [Related]
56. Bronchiolitis obliterans syndrome after allogeneic hematopoietic SCT: phenotypes and prognosis. Bergeron A; Godet C; Chevret S; Lorillon G; Peffault de Latour R; de Revel T; Robin M; Ribaud P; Socié G; Tazi A Bone Marrow Transplant; 2013 Jun; 48(6):819-24. PubMed ID: 23208317 [TBL] [Abstract][Full Text] [Related]
57. Bronchiolitis obliterans and airways obstruction associated with graft-versus-host disease. Epler GR Clin Chest Med; 1988 Dec; 9(4):551-6. PubMed ID: 3069287 [TBL] [Abstract][Full Text] [Related]
58. Effect of Ruxolitinib on Lung Function after Allogeneic Stem Cell Transplantation. Bondeelle L; Chevret S; Hurabielle C; Samy L; Goletto T; Costantini A; Sicre de Fontbrune F; Michonneau D; Socié G; Tazi A; Bouaziz JD; Bergeron A Biol Blood Marrow Transplant; 2020 Nov; 26(11):2115-2120. PubMed ID: 32738501 [TBL] [Abstract][Full Text] [Related]
59. Nintedanib in Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation. Tang W; Yu T; Dong T; Liu T; Ji J Chest; 2020 Sep; 158(3):e89-e91. PubMed ID: 32892892 [TBL] [Abstract][Full Text] [Related]